Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Fibrosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00410462
What this trial is testing

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
European Organisation for Research and Treatment of Cancer - EORTC 118
Testing effectiveness (Phase 2)Study completedNCT00503295
What this trial is testing

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

Who this might be right for
OsteosarcomaEwing Sarcoma Family TumorsMalignant Fibrous Histiocytoma+3 more
Oncolytics Biotech 53
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Not applicableStudy completedNCT05236257
What this trial is testing

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database

Who this might be right for
Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene FusionInfantile Fibrosarcoma
Bayer 93
Testing effectiveness (Phase 2)Study completedNCT02584309
What this trial is testing

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft TissueSoft Tissue SarcomaUndifferentiated Pleomorphic Sarcoma+8 more
Washington University School of Medicine 73
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00112463
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more
National Cancer Institute (NCI) 40
Not applicableWithdrawnNCT00334984
What this trial is testing

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00068367
What this trial is testing

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
Sarcoma
SWOG Cancer Research Network 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743554
What this trial is testing

Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
MPNST (Malignant Peripheral Nerve Sheath Tumor)
Girish Dhall, MD 23
Not applicableStudy completedNCT01567046
What this trial is testing

Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas

Who this might be right for
Childhood Alveolar Soft-part SarcomaChildhood AngiosarcomaChildhood Desmoplastic Small Round Cell Tumor+12 more
Children's Oncology Group 70
Testing effectiveness (Phase 2)UnknownNCT04480502
What this trial is testing

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

Who this might be right for
Undifferentiated Pleomorphic SarcomaMyxofibrosarcoma
Tracon Pharmaceuticals Inc. 207
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Large-scale testing (Phase 3)Study completedNCT00003212
What this trial is testing

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 780
Testing effectiveness (Phase 2)Study completedNCT03433183
What this trial is testing

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1
Sarcoma Alliance for Research through Collaboration 21
Testing effectiveness (Phase 2)Study completedNCT00064220
What this trial is testing

Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Daiichi Sankyo
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Testing effectiveness (Phase 2)Study completedNCT00304083
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neurofibromatosis Type 1Sarcoma
Sarcoma Alliance for Research through Collaboration 48
Next Page